Nasdaq Down 1.5%; Microsoft Posts Upbeat Results
Portfolio Pulse from Lisa Levin
US stocks traded lower with the Nasdaq Composite falling 1.5%. Microsoft Corporation posted stronger-than-expected results for its fiscal first quarter. Abri SPAC I, Inc., ReShape Lifesciences Inc., and BioXcel Therapeutics, Inc. saw their shares rise. Meanwhile, Sonnet BioTherapeutics Holdings, Inc., Appreciate Holdings, Inc., and Vicor Corporation saw their shares drop.
October 25, 2023 | 1:57 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Abri SPAC I, Inc. shares shot up 136% after its stockholders approved its proposed business combination with DLQ.
The approval of the business combination with DLQ is a positive development for Abri SPAC, which is reflected in the surge in its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
BioXcel Therapeutics, Inc. shares rose 36% after announcing positive findings from an independent third party audit of the data integrity at TRANQUILITY II Phase 3 trial site.
The positive findings from the audit of the data integrity at the Phase 3 trial site is a positive development for BioXcel Therapeutics, which is reflected in the rise in its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Microsoft Corporation posted stronger-than-expected results for its fiscal first quarter.
Microsoft's better-than-expected earnings report is likely to have a positive impact on its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Shares of ReShape Lifesciences Inc. shot up 36% after the company recently announced pricing of $3.0 million public offering.
The announcement of the pricing of a $3.0 million public offering is a positive development for ReShape Lifesciences, which is reflected in the rise in its stock price.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Shares of Appreciate Holdings, Inc. were down 34% after the company received a notice from Nasdaq regarding delisting.
The notice of delisting from Nasdaq is a negative development for Appreciate Holdings, which is reflected in the drop in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Sonnet BioTherapeutics Holdings, Inc. shares dropped 35% as the company reported pricing of $4.55 million underwritten public offering.
The announcement of the pricing of a $4.55 million underwritten public offering is a negative development for Sonnet BioTherapeutics, which is reflected in the drop in its stock price.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Vicor Corporation was down, falling 27% after reporting results for the third quarter.
The company's third quarter results seem to have disappointed investors, leading to a drop in its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100